Similar articles

• Antimetastasis effect of two derivatives of epiposophyllotoxin in mice.

  Cattan A, Pourny C, Carpentier Y, Cattan E, Barouh M. Cattan A, et al. Eur J Cancer (1965). 1976 Oct;12(10):797-805. doi: 10.1016/0014-2964(76)90094-3. Eur J Cancer (1965). 1976. PMID: 976288 No abstract available.
• Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer.

  Utsugi T, Shibata J, Sugimoto Y, Aoyagi K, Wierzba K, Kobunai T, Terada T, Oh-hara T, Tsuruo T, Yamada Y. Utsugi T, et al. Cancer Res. 1996 Jun 15;56(12):2809-14. Cancer Res. 1996. PMID: 8665518
• Activity and pharmacokinetics of teniposide in Lewis lung carcinoma-bearing mice.

  Broggini M, Colombo T, D'Incalci M. Broggini M, et al. Cancer Treat Rep. 1983 Jun;67(6):555-9. Cancer Treat Rep. 1983. PMID: 6861161
• Etoposide (VP-16-213).

  Issell BF, Crooke ST. Issell BF, et al. Cancer Treat Rev. 1979 Jun;6(2):107-24. doi: 10.1016/s0305-7372(79)80045-6. Cancer Treat Rev. 1979. PMID: 385138 Review. No abstract available.
• Selective antimetastatic treatment--current status and future prospects.

  Spreafico F, Garattini S. Spreafico F, et al. Cancer Treat Rev. 1974 Dec;1(4):239-50. doi: 10.1016/s0305-7372(74)80017-4. Cancer Treat Rev. 1974. PMID: 4619577 Review. No abstract available.